Transurethral Needle Ablation of the Prostate (TUNA): References

Cornu, J. N., Desgrandchamps, F., de la Taille, A., Vicaut, E., Aout, M., & Lukacs, B. (2012). Prospective Short-Term Evaluation of Transurethral Needle Ablation Procedure in an Ambulatory Setting. Urologia internationalis, 89(4), 451-456.

Xylinas, E., Le Gal, S., & Descazeaud, A. (2010). [Transurethral needle ablation Prostiva for treating symptomatic benign prostatic hyperplasia: a review].Prog Urol, 20(8), 566-571.

Hill B, et al. Transurethral needle ablation versus transurethral resection of the prostate for the treatment of symptomatic benign prostatic hyperplasia: 5-year results of a prospective, randomized, multicenter clinical trial. J Urol. 2004 Jun;171.

Lusuardi L, Hruby S, Janetschek G. New emerging technologies in benign prostatic hyperplasia. Curr Opin Urol. 2012 Nov 7.

Rosario DJ, et al. Safety and efficacy of transurethral needle ablation of the prostate for symptomatic outlet obstruction. Br J Urol. 1997 Oct;80(4):579-86.

Rosario DJ, Phillips JT, Chapple CR. Durability and cost-effectiveness of transurethral needle ablation of the prostate as an alternative to transurethral resection of the prostate when alpha-adrenergic antagonist therapy fails. J Urol. 2007 Mar;177(3):1047-51.

Steele GS, Sleep DJ. Transurethral needle ablation of the prostate: a urodynamic based study with 2-year followup. J Urol. 1997 Nov;158(5):1834-8.